These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1153 related articles for article (PubMed ID: 7399746)
1. The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients. de Vries JE; Mendelsohn J; Bont WS Int J Cancer; 1980 Jan; 25(1):73-84. PubMed ID: 7399746 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures. Troye M; Vilien M; Pape GR; Perlmann P Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743 [TBL] [Abstract][Full Text] [Related]
3. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3). Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141 [TBL] [Abstract][Full Text] [Related]
4. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions. Richter M; Kazaniwsky N Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351 [TBL] [Abstract][Full Text] [Related]
6. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients. de Vries JE; Rümke P Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943 [TBL] [Abstract][Full Text] [Related]
7. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors. de Vries JE; Meyering M; van Dongen A; Rümke P Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313 [TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients. Yanagawa E; Uchida A; Kokoschka EM; Micksche M Cancer Immunol Immunother; 1984; 16(3):131-6. PubMed ID: 6200209 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations. O'Neill PA; Mackler BF; Romsdahl MM J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell. Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952 [TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity. Nishiya K; Horwitz DA J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699 [TBL] [Abstract][Full Text] [Related]
12. Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines. Chang ZL; Hoffman T; Stevenson HC; Trinchieri G; Herberman RB Scand J Immunol; 1983 Nov; 18(5):451-9. PubMed ID: 6648368 [TBL] [Abstract][Full Text] [Related]
13. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor. Richter M; Banerjee D; Sklar S Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271 [TBL] [Abstract][Full Text] [Related]
14. The role of target cells, monocytes, and Fc receptor-bearing lymphocytes in human spontaneous cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity. de Vries JE; Mendelsohn J; Bont WS J Immunol; 1980 Jul; 125(1):396-405. PubMed ID: 7381206 [No Abstract] [Full Text] [Related]
15. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma. Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430 [TBL] [Abstract][Full Text] [Related]
16. Requirement for monocytes in the spontaneous cytotoxic effects of human lymphocytes against non-lymphoid target cells. de Vries JE; Mendelsohn J; Bont WS Nature; 1980 Feb; 283(5747):574-6. PubMed ID: 7354840 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells? Pross HF; Baines MG; Jondal M Int J Cancer; 1977 Sep; 20(3):353-8. PubMed ID: 903188 [TBL] [Abstract][Full Text] [Related]
19. Antibody dependent cellular cytotoxicity and mitogen responsiveness of human peripheral blood lymphocytes differing in avidity for sheep erythrocytes. Jónsdóttir I; Dillner-Centerlind ML; Perlmann H; Perlmann P Scand J Immunol; 1979; 10(6):525-33. PubMed ID: 542806 [TBL] [Abstract][Full Text] [Related]
20. Human peripheral Nullymphocytes: ultrastructural aspects of the "K" cell effect against a melanoma target cell. Cesarini JP; Roubin R; Kalden JR; Peter HH Biomedicine; 1978; 28(4):219-25. PubMed ID: 737273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]